Voya Investment Management LLC Catalyst Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 41,951 shares of CPRX stock, worth $864,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,951

Previous 38,866 7.94%

Holding current value

$864,190

Previous $602,000 38.37%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.19 - $21.35 $46,861 - $65,864	3,085 Added 7.94%	41,951 $833,000
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $72,299 - $83,331	4,925 Added 14.51%	38,866 $602,000
Q1 2024 May 15, 2024	SELL	$13.18 - $17.11 $79,000 - $102,557	-5,994 Reduced 15.01%	33,941 $541,000
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $6,349 - $9,319	539 Added 1.37%	39,935 $671,000
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $2.76 Million - $3.54 Million	-235,934 Reduced 85.69%	39,396 $460,000
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $2.66 Million - $4.17 Million	230,901 Added 519.71%	275,330 $3.7 Million
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $171,219 - $251,337	-11,940 Reduced 21.18%	44,429 $736,000
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $30,845 - $49,101	-2,518 Reduced 4.28%	56,369 $1.05 Million
Q3 2022 Mar 03, 2023	BUY	$7.06 - $15.52 $17,777 - $39,079	2,518 Added 4.47%	58,887 $755,000
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $151,338 - $332,686	21,436 Added 57.24%	58,887 $756,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $8,123 - $11,175	-1,304 Reduced 3.36%	37,451 $263,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $4,850 - $6,935	-931 Reduced 2.35%	38,755 $262,000
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $25,010 - $35,271	-5,830 Reduced 12.81%	39,686 $228,000
Q1 2021 May 17, 2021	BUY	$3.45 - $4.69 $10,291 - $13,990	2,983 Added 7.01%	45,516 $210,000
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $27,027 - $34,853	9,100 Added 27.22%	42,533 $142,000
Q2 2020 Aug 14, 2020	SELL	$3.48 - $5.05 $51,413 - $74,608	-14,774 Reduced 30.65%	33,433 $154,000
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $33,518 - $52,058	9,133 Added 23.37%	48,207 $181,000
Q2 2019 Aug 14, 2019	SELL	$2.7 - $6.11 $5,602 - $12,678	-2,075 Reduced 5.04%	39,074 $150,000
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $18,477 - $31,395	8,176 Added 24.8%	41,149 $128,000
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $79,135 - $96,940	32,973	32,973 $83,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Catalyst Pharmaceuticals, Inc. Transaction History